Get started
Author

Wout De Wispelaere

Observed names: De Wispelaere, Wout, Wout de Wispelaere
Institution: KU Leuven
ORCID: 0000-0002-7513-9002
Observed ORCID: 0000-0002-7513-9002
OpenAlex ID: A5045638142
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers
2022 · Tom Van Nyen, Mélanie Planque, et al. · Nature Communications · 48
PDF
Next generation point-of-care test for therapeutic drug monitoring of adalimumab in patients diagnosed with autoimmune diseases
2022 · Henry Ordutowski, Francesco Dal Dosso, et al. · Biosensors and Bioelectronics · 38
PDF
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD‐1 blockade
2024 · Wout De Wispelaere, Daniela Annibali, et al. · Clinical and Translational Medicine · 27
PDF
The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma
2022 · Raul Maia Falcão, Georgia Kokaraki, et al. · Cancers · 13
PDF
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
2021 · Wout De Wispelaere, Daniela Annibali, et al. · Cancers · 11
PDF
Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State
2025 · Youssef El Laithy, Willy Antoni Abreu De Oliveira, et al. · Cancer Research · 7
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
2025 · Dhanya Ramachandran, Xuemin Wang, et al. · EBioMedicine · 6
PDF
Germline copy number variants and endometrial cancer risk
2024 · Cassie E. Stylianou, George A. R. Wiggins, et al. · Human Genetics · 4
PDF
2022-RA-953-ESGO Serine metabolism remodeling after platinum-based chemotherapy is a new vulnerability in resistant ovarian cancer patients
2022 · Tom van Nyen, Mélanie Planque, et al. · International Journal of Gynecological Cancer · 2
PDF
Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial
2026 · Regina Esi Mensimah Baiden-Amissah, Sandra Tuyaerts, et al. · Frontiers in Immunology
PDF
Feasibility of a rapid post-mortem tissue donation program to study epithelial ovarian cancer
2026 · Gitte Hoorelbeke, Jonathan Servayge, et al. · International Journal of Gynecological Cancer
PETITE Collection: An Ex Vivo Platform For Personalized Therapeutic Testing In Gynaecological Cancers
2025 · Alejandro Herreros Pomares, Rossana Benedetto, et al. · International Journal of Gynecological Cancer
Works count: 14
Citation count: 156
H-index: 6
I10-index: 5
Year
Topic
Type